Delivery Order SPE2DE24DA017-SPE2D626F36KQ
- Not listed
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $8,804.40 by the Defense Logistics Agency's Medical Supply Chain on January 13, 2026. The order covers suture anchors with bio-composite construction measuring 2.9 x 12.5mm, with an ultimate completion date of January 16, 2026. This award was issued under Arthrex's existing single-award Indefinite Delivery Contract (SPE2DE24D0020) valued at $471 million and...
- Arthrex Inc., a leading manufacturer of minimally invasive orthopedic medical devices headquartered in Naples, Florida, was awarded a delivery order valued at $13,516.60 on January 22, 2026, for suture anchors (1.8MM, quantity 2) under a fixed-price contract with economic price adjustment provisions. The delivery order, which carries an ultimate completion date of February 5, 2026, was issued without set-aside designation, reflecting Arthrex's established competitive position in federal...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $4,845.80 on July 31, 2025, for suture anchors (1.8mm, 2-pack, 1 single unit) with an ultimate completion date of August 14, 2025. This fixed-price delivery order with economic price adjustment was issued under the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal agency, with performance to be executed in Naples, Florida. The...
- Arthrex Inc., a leading minimally invasive orthopedic medical technology company headquartered in Naples, Florida, was awarded a delivery order valued at $4,402.20 by the Defense Logistics Agency's Medical Supply Chain on September 12, 2025. The delivery order, which covers a suture anchor bio-composite product (2.9 x 12.5mm), is structured as a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of September 17, 2025. This award does not...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,339.70 on July 24, 2025, by the Defense Logistics Agency's Medical Supply Chain for suture anchors and related orthopedic components. The contract, designated as fixed price with economic price adjustment pricing, carries an ultimate completion date of August 7, 2025, and was awarded without a set-aside designation, reflecting Arthrex's strong...
- Arthrex Inc., a Naples, Florida-based orthopedic medical technology company, received a $4,624.00 delivery order from the Defense Logistics Agency's Medical Supply Chain on September 4, 2025, for suture anchors (1.8mm, 2-pack, 1 set). This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by September 17, 2025, and will be performed in Naples, Florida. The award represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $4,886.08 on October 29, 2025, for suture anchor biologics and related orthopedic products. The contract, which carries a fixed-price structure with economic price adjustment provisions, is scheduled for completion by November 3, 2025, and will be performed at Arthrex's Naples facility. This delivery order was issued without set-aside designation, reflecting the...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a $7,268.70 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 11, 2025, for suture anchors (1.8MM 2 1S). The delivery order, which carries an ultimate completion date of September 25, 2025, represents a task order issued under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) valued at $471 million and running through September 1, 2029. The...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, has been awarded a delivery order valued at $21,825.77 for suture anchors, bio-composite P-lock, 2.9 x 12.5mm. The award, issued on May 5, 2025, with an ultimate completion date of May 8, 2025, represents a fixed-price contract with economic price adjustment under the Defense Logistics Agency's Medical Supply Chain. This delivery order carries no set-aside designation, reflecting Arthrex's...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,980.00 on August 12, 2025, for suture anchors (SUTR ANCH, PEEK P-LCK, 2.9 x 12.5MM) to support the Defense Logistics Agency's Medical Supply Chain. The contract, which employs fixed-price pricing with economic price adjustment provisions, is scheduled for completion by August 15, 2025, and will be performed in Naples, Florida. No set-aside designation...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F36KQDelivery Order
Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, has been awarded a delivery order valued at $4,402.20 for suture anchors (model 4570686607, SUT ANCH 4.75X19.1 5S) with a fixed-price contract structure that includes economic price adjustment provisions. The contract, awarded on February 3, 2026, has an ultimate completion date of February 13, 2026, and will be performed at Arthrex's Naples facility. This delivery order was issued without a set-aside designation, reflecting the company's competitive standing in federal procurement. The order is funded through the Defense Logistics Agency's Medical Supply Chain, which supports orthopedic surgical requirements across Department of Defense and Department of Veterans Affairs healthcare systems. This delivery order is issued under Arthrex's existing Indefinite Delivery Contract SPE2DE24D0020 with the Defense Logistics Agency's Medical Supply Chain, a comprehensive master contract valued at $471 million and effective through September 1, 2029. The parent IDC authorizes procurement of a full spectrum of orthopedic products and surgical technologies, including surgical implants, arthroscopic instruments, joint replacement systems, and biologics, supporting military and veteran healthcare facilities nationwide. As a prime contractor with no subcontractors, Arthrex has established a direct relationship with the federal government and maintains the capacity to fulfill orthopedic requirements independently across multiple surgical specialties.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 2/2/26 |